OIG: Drugmakers should disclose wholesale prices to CMS

04/27/2011 | Hill, The

Medicare could save $4.4 million each year by reducing reimbursement for drugs covered under Part B that have an average sale price at least 5% more than the wholesale price, according to an HHS Inspector General's report. The CMS responded by saying doing so would violate a court order against disclosing wholesale prices to the public.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT